Semaglutide vs BPC-157
A comprehensive, data-driven comparison of Semaglutide (Ozempic) and BPC-157 (Body Protection Compound-157). Compare efficacy, side effects, costs, FDA approval status, and clinical evidence to make an informed decision.
Side-by-Side Comparison
| Property | Semaglutide Ozempic, Wegovy | BPC-157 Body Protection Compound-157, PL 14736 |
|---|---|---|
| FDA Status | FDA Approved | Category 2 (pending reclassification) |
| Category | Weight Loss | Recovery & Healing |
| Primary Use | Type 2 diabetes, chronic weight management, and MASH | Tissue healing and injury recovery |
| Weight Loss % | 15% | N/A |
| Monthly Cost | $1,000 - $1,400/mo | $50 - $120/mo |
| Administration | Subcutaneous injection | Subcutaneous injection |
| Typical Dose | 2.4mg weekly (Wegovy dose) | 250-500mcg daily |
| Frequency | Weekly | Daily |
| Mechanism | GLP-1 receptor agonist that mimics incretin hormone to increase insulin secretion, slow gastric emptying, and reduce appetite | Synthetic peptide derived from gastric juice protein that promotes angiogenesis, modulates growth factors, and accelerates tissue repair |
| Common Side Effects |
|
|
| Serious Side Effects |
|
|
| Evidence Quality | High | Low |
| Clinical Trial Phase | Approved | N/A |
Key Differences
- 1Semaglutide is FDA-approved, while BPC-157 is currently category 2 (pending reclassification).
- 2Semaglutide has clinical weight loss data (15%), while BPC-157 is not primarily indicated for weight loss.
- 3BPC-157 is generally more affordable ($50 - $120/mo) compared to Semaglutide ($1,000 - $1,400/mo).
- 4Semaglutide is dosed weekly, while BPC-157 is daily.
- 5Semaglutide has high-quality evidence, while BPC-157 has low-quality evidence.
- 6They belong to different categories: Semaglutide (Weight Loss) vs BPC-157 (Recovery & Healing).
Which Is Better For...
Semaglutide
Those seeking an FDA-approved treatment with established safety data
BPC-157
More budget-friendly option with lower monthly costs
Semaglutide
More convenient dosing schedule (weekly)
BPC-157
Fewer commonly reported side effects
Semaglutide
Stronger clinical evidence base to support its use
Cost Comparison
| Peptide | Monthly Cost Range | FDA Status | Manufacturer |
|---|---|---|---|
| Semaglutide | $1,000 - $1,400/mo | FDA Approved | Novo Nordisk |
| BPC-157 | $50 - $120/mo | Category 2 (pending reclassification) | Various research labs |
Prices are estimated monthly costs and may vary based on pharmacy, insurance coverage, and manufacturer assistance programs. Costs for non-FDA-approved peptides reflect research compound pricing.
Frequently Asked Questions
Semaglutide works via GLP-1 receptor agonist that mimics incretin hormone to increase insulin secretion, slow. BPC-157 works via Synthetic peptide derived from gastric juice protein that promotes angiogenesis, modulates growth. They differ in FDA approval status, efficacy data, and cost.
Semaglutide has demonstrated 15% average weight loss in clinical trials. BPC-157 is not primarily used for weight loss.
Semaglutide typically costs $1,000 - $1,400/mo, while BPC-157 costs $50 - $120/mo. Prices may vary by pharmacy, insurance coverage, and manufacturer programs.
Semaglutide is FDA-approved. BPC-157 is not FDA-approved (Category 2 (pending reclassification)). FDA approval indicates the treatment has met rigorous safety and efficacy standards.
Common side effects of Semaglutide include Nausea, Diarrhea, Vomiting. Common side effects of BPC-157 include Injection site discomfort, Mild headache, Dizziness. Always consult a healthcare provider about potential side effects.
Switching between peptide therapies should only be done under the guidance of a qualified healthcare provider. They can evaluate your medical history, current response, and determine the safest transition protocol.
Learn More
Semaglutide is an FDA-approved GLP-1 receptor agonist marketed as Ozempic for type 2 diabetes and Wegovy for chronic weight management. In August 2025, it received accelerated approval for MASH (metab...
View Full Semaglutide GuideBPC-157 is a synthetic peptide consisting of 15 amino acids derived from a protective protein found in human gastric juice. Although not FDA-approved, it has gained significant attention in research a...
View Full BPC-157 GuideOther Popular Comparisons
Medical Disclaimer
The information provided on this page is for educational and informational purposes only and does not constitute medical advice. This comparison between Semaglutide and BPC-157 should not be used as a substitute for professional medical guidance. Always consult a qualified healthcare provider before starting, stopping, or modifying any peptide therapy. Clinical data cited may be from ongoing trials and is subject to change. Individual results may vary significantly. PeptideVS does not endorse, recommend, or promote the use of any specific peptide for medical treatment.